eMed logo

eMed

Challenger

Raised $200M Series A (Mar 2026) at $2B+ valuation led by AON Consulting. 91%+ medication adherence. GLP-1 benefits platform for employers. Linda Yaccarino CEO.

Best for: Metabolic Health
48
AI Score
Grade C↑ Trending
AI Visibility Score (Beta)
HealthcareMetabolic HealthWebsiteUpdated April 2026

Brand Intelligence Graph

Capabilities
Metabolic Health

Company Overview

About eMed

eMed is a GLP-1 and metabolic health benefits platform built specifically for employer-sponsored health plans, the fastest-growing category in US workplace benefits. The company raised $200 million in Series A financing in March 2026 at a $2 billion+ valuation led by AON Consulting, with backing from Linda Yaccarino (former Twitter/X CEO, now eMed CEO) and Tom Brady. Claiming 91%+ medication adherence rates, eMed positions itself as the most effective GLP-1 benefits program available to employers.

Business Model & Competitive Advantage

The platform's capitated pricing model shifts financial risk from employers to eMed — charging a fixed fee per member regardless of how many GLP-1 prescriptions are written — which makes total cost predictable for HR and benefits teams wrestling with runaway drug spend. GLP-1 medications (Ozempic, Wegovy) have become the most requested workplace health benefit in the US, and their list prices create budget pressure that employers urgently need managed.

Competitive Landscape 2025–2026

eMed combines clinical oversight (prescribers, pharmacists, registered dietitians) with behavioral coaching and medication management to improve outcomes and reduce GLP-1 discontinuation, which runs 50-70% in typical commercial populations. The company's approach is to treat GLP-1 therapy as a managed clinical program rather than a pharmacy benefit, driving the adherence rates it claims as a differentiator.

Curated content • Fact-checked and verified

Key Differentiators

Strong Challenger

eMed is an established challenger with significant market presence and competitive offerings in Digital Health.

Frequently Asked Questions

Estimated Visibility Trend (Beta)

Simulated 8-week rolling score

48
↑ Trending

Based on estimated brand signals. Historical tracking coming soon.

Similar Brands

PointClickCare logo

PointClickCare

Senior Care Tech
B2bB2cEnterpriseHealthtechPlatformSaasUnicorn

PointClickCare is North America's leading cloud-based software platform for the long-term and post-acute care (LTPAC) market, headquartered in Mississauga, Ontario, Canada. Founded in 1999, the compan

Veeva Systems logo

Veeva Systems

Healthcare Tech
B2bHealthtechSaasPublic

Veeva Systems Inc. is the leading cloud software provider for the global life sciences industry, headquartered in Pleasanton, California. Founded in 2007 by Peter Gassner (a former Salesforce executiv

Oracle Health logo

Oracle Health

Healthcare
HealthtechNorth AmericaB2b

Oracle Health is the healthcare technology business unit of Oracle Corporation (NYSE: ORCL) — providing electronic health records (EHR), clinical workflow management, health information exchange, reve

athenahealth logo

athenahealth

Healthcare
B2bCloud NativeEnterpriseErpHealthtechNorth AmericaSaas

athenahealth is a cloud-based electronic health records (EHR), medical billing, and practice management company founded in 1997 and headquartered in Watertown, Massachusetts. The company was built on

Idexx Laboratories logo

Idexx Laboratories

Healthcare Tech
B2bHealthtechManufacturingSaasPublic

IDEXX Laboratories is the global leader in veterinary diagnostics and information technology for companion animal healthcare, founded in 1983 by David Shaw in Westbrook, Maine, where it remains headqu

Revvity logo

Revvity

Healthcare Tech
B2bHealthtechManufacturingSaasPublic

Revvity, Inc. (formerly PerkinElmer) is a global life science tools and diagnostics company, rebranded in 2023 to signal its transformation from a diversified instruments company into a focused provid

Compare eMed with Competitors

Side-by-side AI visibility scores, platform breakdown, and market position.

For eMed

Claim This Profile

Are you from eMed? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.

Claim eMed Profile →
For competitors & analysts

Track AI Visibility in Real Time

Monitor how ChatGPT, Gemini, Perplexity, and Claude mention eMed vs competitors. Get alerts when AI recommendations shift.

Start Free Tracking →